Multidrug-resistant TB is on the rise and the current available tools for TB diagnosis, treatment and prevention are not adequate.

Donate Now


Gift in Memory: If you are making this donation in memory of someone, please let us know their name, and the name of the Next of Kin (if known) so we can let them know you are thinking of their loved one.

If you would like to include a message for the family, please email it to [email protected].
NB. Privacy laws prevent us from disclosing the amount you gifted.

Loading PayPal button. Please wait...

Need assistance? Please call us on +61 3 9282 2111 and quote your unique donation ID '7b0967' so that we can assist you.

Every second, someone in the world is newly infected with tuberculosis (TB), a highly contagious air-borne disease.

Tuberculosis (TB) should be treatable with a six-month course of antibiotics. But in some countries the bacteria is becoming increasingly drug-resistant and is presenting major concerns among health workers.

For people who have a weakened immune system the disease can be come life threatening and fatal if not treated properly.

Each year an estimated 1.3 million people die from TB. Infection rates are on the rise in South-east Asia and Africa, especially Papua New Guinea. The Asia and Pacific regions carry 58 percent of the global burden of TB and 54 percent of DR-TB.

Although progress towards global targets for reductions in TB cases and deaths in recent years has been impressive according the World Health Organization, the global burden remains significant.

Multidrug-Resistant TB

At Burnet, of most concern is the emergence of multidrug-resistant TB and this is the focus of much of our work in Myanmar, Papua New Guinea and Timor-Leste. which involves:

  • Monitoring drug-resistant TB in the Pacific
  • Understanding how these drug resistant strains spread within certain populations in Africa and Papua New Guinea
  • Looking at how we can help build the most appropriate health systems to deal with this emerging problem
  • Developing new rapid diagnostic tools to help manage patient care

You can support our TB work by donating today.